I just saw these today and they are a few months old but worth a read. They both appear to be very few in numbers but serious. Contact your neurologist if there are questions or concerns.
Lemtrada (alemtuzumab)
https://www.fda.gov/Drugs/DrugSafety/ucm624247.htm
Gilenya (fingolimod)
https://www.fda.gov/Drugs/DrugSafety/ucm626095.htm
Lemtrada (alemtuzumab)
https://www.fda.gov/Drugs/DrugSafety/ucm624247.htm
Gilenya (fingolimod)
https://www.fda.gov/Drugs/DrugSafety/ucm626095.htm
Comment